Impaired T Cell Protein Kinase Cδ Activation Decreases ERK Pathway Signaling in Idiopathic and Hydralazine-Induced Lupus
Authors:
- 15 October 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 179 (8) , 5553-5563
Abstract
T cells from patients with lupus or treated with the lupus-inducing drug hydralazine have defective ERK phosphorylation. The reason for the impaired signal transduction is unknown but important to elucidate, because decreased T cell ERK pathway signaling causes a lupus-like disease in animal models by decreasing DNA methyltransferase expression, leading to DNA hypomethylation and overexpression of methylation-sensitive genes with subsequent autoreactivity and autoimmunity. We therefore analyzed the PMA stimulated ERK pathway phosphorylation cascade in CD4+ T cells from patients with lupus and in hydralazine-treated cells. The defect in these cells localized to protein kinase C (PKC)δ. Pharmacologic inhibition of PKCδ or transfection with a dominant negative PKCδ mutant caused demethylation of the TNFSF7 (CD70) promoter and CD70 overexpression similar to lupus and hydralazine-treated T cells. These results suggest that defective T cell PKCδ activation may contribute to the development of idiopathic and hydralazine-induced lupus through effects on T cell DNA methylation.Keywords
This publication has 52 references indexed in Scilit:
- Activation of ERK during DNA damage-induced apoptosis involves protein kinase CδBiochemical and Biophysical Research Communications, 2005
- Stimulus-induced phosphorylation of PKC θ at the C-terminal hydrophobic-motif in human T lymphocytesBiochemical and Biophysical Research Communications, 2005
- Phorbol 12-Myristate 13-Acetate Induces Epidermal Growth Factor Receptor Transactivation via Protein Kinase Cδ/c-Src Pathways in Glioblastoma CellsJournal of Biological Chemistry, 2005
- Activation and translocation of PKCδ is necessary for VEGF-induced ERK activation through KDR in HEK293T cellsBiochemical and Biophysical Research Communications, 2004
- Rottlerin, a Novel Protein Kinase InhibitorBiochemical and Biophysical Research Communications, 1994
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosusClinical Immunology and Immunopathology, 1991
- CD4+ cells treated with DNA methylation inhibitors induce autologous B cell differentiationClinical Immunology and Immunopathology, 1990
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Effect of an inhibitor of DNA methylation on T cells. II. 5-azacytidine induces self-reactivity in antigen-specific T4+ cellsHuman Immunology, 1986